Compounds > benzyloxycarbonyl-phe-ala-fluormethylketone

Page last updated: 2024-09-03

benzyloxycarbonyl-phe-ala-fluormethylketone and 10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone

benzyloxycarbonyl-phe-ala-fluormethylketone has been researched along with 10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone in 1 studies

Compound Research Comparison

Studies (benzyloxycarbonyl-phe-ala-fluormethylketone)	Trials (benzyloxycarbonyl-phe-ala-fluormethylketone)	Recent Studies (post-2010) (benzyloxycarbonyl-phe-ala-fluormethylketone)	Studies (10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone)	Trials (10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone)	Recent Studies (post-2010) (10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone)
5	0	5	8	0	4

Protein Interaction Comparison

Protein	Taxonomy	benzyloxycarbonyl-phe-ala-fluormethylketone (IC50)	10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone (IC50)
Potassium voltage-gated channel subfamily KQT member 2	Homo sapiens (human)		0.048

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Johnson, BM; Meanwell, NA; Shu, YZ; Zhuo, X	1

Other Studies

1 other study(ies) available for benzyloxycarbonyl-phe-ala-fluormethylketone and 10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone

Article	Year
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds. Journal of medicinal chemistry, 2020, 06-25, Volume: 63, Issue:12 Topics: Drug Design; Fluorine; Halogenation; Humans; Pharmaceutical Preparations	2020